1. Home
  2. GROW vs AKTX Comparison

GROW vs AKTX Comparison

Compare GROW & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GROW
  • AKTX
  • Stock Information
  • Founded
  • GROW 1968
  • AKTX N/A
  • Country
  • GROW United States
  • AKTX United States
  • Employees
  • GROW N/A
  • AKTX N/A
  • Industry
  • GROW Investment Managers
  • AKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GROW Finance
  • AKTX Health Care
  • Exchange
  • GROW Nasdaq
  • AKTX Nasdaq
  • Market Cap
  • GROW 32.9M
  • AKTX 32.8M
  • IPO Year
  • GROW N/A
  • AKTX N/A
  • Fundamental
  • Price
  • GROW $2.46
  • AKTX $1.24
  • Analyst Decision
  • GROW
  • AKTX
  • Analyst Count
  • GROW 0
  • AKTX 0
  • Target Price
  • GROW N/A
  • AKTX N/A
  • AVG Volume (30 Days)
  • GROW 30.9K
  • AKTX 25.4K
  • Earning Date
  • GROW 02-12-2025
  • AKTX 02-15-2025
  • Dividend Yield
  • GROW 3.67%
  • AKTX N/A
  • EPS Growth
  • GROW N/A
  • AKTX N/A
  • EPS
  • GROW 0.12
  • AKTX N/A
  • Revenue
  • GROW $10,008,000.00
  • AKTX N/A
  • Revenue This Year
  • GROW N/A
  • AKTX N/A
  • Revenue Next Year
  • GROW N/A
  • AKTX N/A
  • P/E Ratio
  • GROW $20.22
  • AKTX N/A
  • Revenue Growth
  • GROW N/A
  • AKTX N/A
  • 52 Week Low
  • GROW $2.38
  • AKTX $0.90
  • 52 Week High
  • GROW $2.95
  • AKTX $4.40
  • Technical
  • Relative Strength Index (RSI)
  • GROW 54.17
  • AKTX 51.97
  • Support Level
  • GROW $2.43
  • AKTX $1.10
  • Resistance Level
  • GROW $2.48
  • AKTX $1.39
  • Average True Range (ATR)
  • GROW 0.04
  • AKTX 0.13
  • MACD
  • GROW 0.00
  • AKTX -0.00
  • Stochastic Oscillator
  • GROW 60.00
  • AKTX 61.54

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

Share on Social Networks: